MedKoo Cat#: 555363 | Name: ZK824859 HCl
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ZK824859 is a selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis.

Chemical Structure

ZK824859 HCl
ZK824859 HCl
CAS#2436760-76-6 (HCl)

Theoretical Analysis

MedKoo Cat#: 555363

Name: ZK824859 HCl

CAS#: 2436760-76-6 (HCl)

Chemical Formula: C23H24Cl2F2N2O4

Exact Mass: 0.0000

Molecular Weight: 501.35

Elemental Analysis: C, 55.10; H, 4.83; Cl, 14.14; F, 7.58; N, 5.59; O, 12.76

Price and Availability

Size Price Availability Quantity
5mg USD 625.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
ZK824859; ZK-824859; ZK 824859; ZK824859 HCl; ZK824859 hydrochloride
IUPAC/Chemical Name
(R)-2-((6-((3'-(Aminomethyl)-5-methyl-[1,1'-biphenyl]-3-yl)oxy)-3,5-difluoropyridin-2-yl)oxy)butanoic acid dihydrochloride
InChi Key
AQXUHWUZKYSBNO-FAVHNTAZSA-N
InChi Code
InChI=1S/C23H22F2N2O4.2ClH/c1-3-20(23(28)29)31-22-19(25)11-18(24)21(27-22)30-17-8-13(2)7-16(10-17)15-6-4-5-14(9-15)12-26;;/h4-11,20H,3,12,26H2,1-2H3,(H,28,29);2*1H/t20-;;/m1../s1
SMILES Code
CC[C@@H](OC1=NC(OC2=CC(C3=CC=CC(CN)=C3)=CC(C)=C2)=C(F)C=C1F)C(O)=O.[H]Cl.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 501.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Islam I, Yuan S, West CW, Adler M, Bothe U, Bryant J, Chang Z, Chu K, Emayan K, Gualtieri G, Ho E, Light D, Mallari C, Morser J, Phillips G, Schaefer C, Sukovich D, Whitlow M, Chen D, Buckman BO. Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis. Bioorg Med Chem Lett. 2018 Nov 1;28(20):3372-3375. doi: 10.1016/j.bmcl.2018.09.001. Epub 2018 Sep 5. PubMed PMID: 30201291.